Tizanidine Tablet
Product Images NDC 68071-4463
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 68071-4463). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-1 (3d3e6e45 9bae 48e9 B49a A4457541002e 02)
Figure 3 (3d3e6e45 9bae 48e9 B49a A4457541002e 03)
Figure 4 (3d3e6e45 9bae 48e9 B49a A4457541002e 04)
Logo (3d3e6e45 9bae 48e9 B49a A4457541002e 05)
68071 4463 3
This is a description of a medication called Tizanidine 4 mg. It is packaged in a bottle with 30 tablets, with Lot number 000000 and NDC number 68071-4463-03. Each tablet is round, white/off-white and scored with a *U* and LOT#: 000000 on the un-scored side. The tablet is quadrisected and contains 4 mg of Tizanidine Hydrochloride, USP equivalent. The bottle label contains information about the manufacturer, production/expiry date, and the National Drug Code (NDC). The patient should contact their doctor for medical advice about possible side effects. The packaging has a warning to keep it out of reach of children and store at a controlled temperature of 68-77°F.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.